Dr. Zahi Touma, MD, PhD - Toronto Western Hospital/ University of Toronto - Assistant Professor of Medicine, Clinician-Scientist

Dr. Zahi Touma

MD, PhD

Toronto Western Hospital/ University of Toronto

Assistant Professor of Medicine, Clinician-Scientist

Toronto, Ontario | Canada

Additional Specialties: Rheumatology

ORCID logohttps://orcid.org/0000-0001-5177-2076

Dr. Zahi Touma, MD, PhD - Toronto Western Hospital/ University of Toronto - Assistant Professor of Medicine, Clinician-Scientist

Dr. Zahi Touma

MD, PhD

Introduction

Primary Affiliation: Toronto Western Hospital/ University of Toronto - Toronto, Ontario , Canada

Additional Specialties:

Research Interests:

Publications

65Publications

1353Reads

3Profile Views

145PubMed Central Citations

Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus.

Semin Arthritis Rheum 2019 Oct 9;49(2):260-266. Epub 2019 Mar 9.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, EW, 1-412, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.03.004DOI Listing
October 2019
1 Read
3.925 Impact Factor

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ).

J Rheumatol 2019 Sep 15;46(9):1192-1197. Epub 2019 Feb 15.

From the Institute of Medical Sciences, Faculty of Medicine, University of Toronto; Department of Diagnostic Imaging, The Hospital for Sick Children; Department of Translational Medicine, SickKids Research Institute, Peter Gilgan Center for Research and Learning; Dalla Lana School of Public Health, University of Toronto; Division of Rheumatology, The Hospital for Sick Children, University of Toronto; Department of Medical Imaging, University of Toronto; Department of Rheumatology, Center for Prognosis Studies in Rheumatologic Diseases, Toronto Western Hospital, Toronto, Ontario; Department of Rheumatology, University of Alberta; Department of Radiology and Diagnostic Imaging, University of Alberta; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, UK; Department of Rheumatology, Leiden University Medical Center, Leiden; Reade | Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Children's Hospital of Philadelphia and Departments of Pediatric and Epidemiology, Philadelphia, Pennsylvania; Department of Radiology, Nemours Children's Hospital and Health System, Orlando, Florida, USA; Department of Radiology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland; Department of Radiology and Medical Imaging, Ghent University Hospital, Ghent, Belgium; Department of Radiology, Hospital Sant Joan de Deu, Barcelona, Spain; Department of Radiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway; Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany; Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India; State University of Campina-UNICAMP, Department of Internal Medicine, Cidade Universitaria, Sao Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181115DOI Listing
September 2019
7 Reads
3.187 Impact Factor

The Assessment of Anxiety and Depression and its Associated Factors in SLE.

Curr Rheumatol Rev 2019 ;15(2):90-98

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1573397114666180926101513DOI Listing
August 2019
20 Reads

Drs. Tayer-Shifman and Touma reply.

J Rheumatol 2019 Jun;46(6):653

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181290DOI Listing
June 2019
1 Read
3.187 Impact Factor

Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken) 2019 Jun 10;71(6):822-828. Epub 2019 May 10.

University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23720DOI Listing
June 2019
1 Read
4.713 Impact Factor

Psoriatic Arthritis Sonographic Enthesitis Instruments: A Systematic Review of the Literature.

J Rheumatol 2019 Jan 15;46(1):43-56. Epub 2018 Jul 15.

From the University of Toronto and Toronto Western Hospital; University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases; University Health Network; Women's College Hospital, Toronto; University of Ottawa, Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; University of Florida College of Medicine, Jacksonville, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171466DOI Listing
January 2019
70 Reads
3.190 Impact Factor

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies.

Patient Relat Outcome Meas 2019 9;10:1-7. Epub 2019 Jan 9.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, ON, Canada,

View Article

Download full-text PDF

Source
https://www.dovepress.com/impact-of-belimumab-on-patient-rep
Publisher Site
http://dx.doi.org/10.2147/PROM.S134326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330963PMC
January 2019
6 Reads

What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis.

Semin Arthritis Rheum 2018 10 21;48(2):240-255. Epub 2018 Feb 21.

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, EW, 1-412, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172173058
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2018.02.007DOI Listing
October 2018
22 Reads
3.925 Impact Factor

Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.

J Rheumatol 2018 Oct 15;45(10):1406-1410. Epub 2018 Jul 15.

From the Toronto Scleroderma Program, Division of Rheumatology, Toronto Western Hospital, University Health Network; Division of Rheumatology, Mount Sinai Hospital, University of Toronto; Institute of Health Policy, Management and Evaluation, and Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Ontario, Canada; Taibah University, Medina, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170953DOI Listing
October 2018
45 Reads
3.190 Impact Factor

Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.

J Rheumatol 2018 Oct 15;45(10):1448-1461. Epub 2018 Aug 15.

From the Division of Rheumatology, Department of Medicine, and the Alberta Research Centre for Health Evidence, and the John W. Scott Health Sciences Library, University of Alberta, Edmonton, Alberta; Division of Rheumatology, Department of Medicine, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, University of Western Ontario, London, Ontario; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171310DOI Listing
October 2018
32 Reads
3.190 Impact Factor

Subcutaneous belimumab in the treatment of systemic lupus erythematosus.

Immunotherapy 2018 09 14;10(13):1163-1173. Epub 2018 Aug 14.

Department of Medicine, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0061
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0061DOI Listing
September 2018
10 Reads
2.440 Impact Factor

Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus.

Clin Exp Rheumatol 2018 Jul-Aug;36(4):545-551. Epub 2018 Apr 13.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Canada.

View Article

Download full-text PDF

Source
September 2018
6 Reads
2.724 Impact Factor

Monophasic Disease Course in Systemic Lupus Erythematosus.

J Rheumatol 2018 Aug 1;45(8):1131-1135. Epub 2018 Jun 1.

From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171319DOI Listing
August 2018
22 Reads
3.190 Impact Factor

A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index.

Rheumatology (Oxford) 2018 08;57(8):1370-1376

Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Lupus Clinic, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key103DOI Listing
August 2018
3 Reads
4.475 Impact Factor

Minimal Clinically Important Difference: A Review of Outcome Measure Score Interpretation.

Rheum Dis Clin North Am 2018 May 21;44(2):177-188. Epub 2018 Feb 21.

Toronto Western Hospital/University Health Network, 399 Bathurst Street, Room 1E-412, Toronto, Ontario M5T 2S8, Canada; Institute of Health Policy, Management & Evaluation, University of Toronto; Health Sciences Building, 155 College Street, Suite 425, Toronto, Ontario M5T 3M6, Canada; Institute for Work & Health, 481 University Avenue, Suite 800, Toronto, Ontario M5G 2E9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2018.01.011DOI Listing
May 2018
2 Reads
2.692 Impact Factor

The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort.

Semin Arthritis Rheum 2017 06 21;46(6):791-797. Epub 2016 Sep 21.

Department of Medicine, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, EW, 1-412, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8; The Institute for Work and Health, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2016.09.008DOI Listing
June 2017
33 Reads
3.925 Impact Factor

Reply.

Arthritis Care Res (Hoboken) 2017 03;69(3):457

University of Toronto, Women's College Research Institute, and Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23001DOI Listing
March 2017
15 Reads
4.713 Impact Factor

Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.

Arthritis Care Res (Hoboken) 2017 01;69(1):67-74

University of Toronto, Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22926DOI Listing
January 2017
10 Reads
6 Citations
4.713 Impact Factor

Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.

Expert Opin Biol Ther 2016 10 29;16(10):1225-38. Epub 2016 Jul 29.

a Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases , University of Toronto Lupus Clinic , Toronto , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2016.1214263DOI Listing
October 2016
15 Reads
1 Citation
3.743 Impact Factor

Utility of Urinary Protein-Creatinine Ratio and Protein Content in a 24-Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Arthritis Care Res (Hoboken) 2016 09 29;68(9):1310-9. Epub 2016 Jul 29.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/acr.22828
Publisher Site
http://dx.doi.org/10.1002/acr.22828DOI Listing
September 2016
13 Reads
4 Citations
4.713 Impact Factor

Systemic lupus erythematosus.

Nat Rev Dis Primers 2016 06 16;2:16039. Epub 2016 Jun 16.

The London Lupus Centre, London Bridge Hospital, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp201639
Publisher Site
http://dx.doi.org/10.1038/nrdp.2016.39DOI Listing
June 2016
97 Reads
23 Citations

Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study.

J Rheumatol 2016 06 1;43(6):1057-62. Epub 2016 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.Z. Touma, MD, FACP, FACR, PhD, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; A. Thavaneswaran, MMath, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; V. Chandran, MBBS, MD, DM, PhD, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; F. Pellett, BsC, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150466DOI Listing
June 2016
18 Reads
1 Citation
3.190 Impact Factor

Proteinuria: Assessment and Utility in Lupus Nephritis

J Rheumatol Muscular Syst 1: 001.

J Rheumatol Muscular Syst

Lupus has an incidence of kidney involvement of 54%. The most common manifestation of lupus nephritis is proteinuria. Proteinuria is a biological marker of disease activity and renal damage and it is included in lupus disease activity and damage indices. Proteinuria produces fibrosis of the renal tubules and interstitium, leading to chronic kidney disease. There is a known association between proteinuria and vascular inflammation, increasing the risk for cardiovascular disease. Clinicians managing lupus can use the Protein-creatinine Ratio (PCR) in a spot urine sample to screen for proteinuria. Although different cut-offs of PCR in order to predict proteinuria levels have been suggested, the gold standard test to accurately quantify proteinuria in lupus is based on the protein content in a 24-hour urine collection.

View Article
December 2015
11 Reads

Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus.

Arthritis Res Ther 2015 Oct 24;17:296. Epub 2015 Oct 24.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies on the Rheumatic Diseases, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0808-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619322PMC
October 2015
24 Reads
2 Citations
3.753 Impact Factor

Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus.

Drug Des Devel Ther 2014 17;8:2303-10. Epub 2014 Nov 17.

University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S49778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242126PMC
August 2015
2 Reads
1 Citation
3.030 Impact Factor

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement.

J Rheumatol 2015 Aug 15;42(8):1401-5. Epub 2015 Jun 15.

From the University of Toronto, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and Toronto Western Research Institute, Toronto, Ontario, Canada.Z. Touma, MD, FACP, FACR, PhD, Assistant Professor of Medicine, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Co-director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto; J. Su, MB, BSc; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141088DOI Listing
August 2015
23 Reads
1 Citation
3.190 Impact Factor

DEVELOPING AN IPAD® APPLICATION FOR DATA COLLECTION IN A RHEUMATOLOGY RESEARCH CLINIC.

Int J Technol Assess Health Care 2015 Jan 20;31(1-2):99-102. Epub 2015 May 20.

University of Toronto,Psoriatic Arthritis Program,University Health Network,Centre for Prognosis Studies in the Rheumatic Diseases,Toronto Western

View Article

Download full-text PDF

Source
http://www.journals.cambridge.org/abstract_S0266462315000069
Publisher Site
http://dx.doi.org/10.1017/S0266462315000069DOI Listing
January 2015
17 Reads
1.560 Impact Factor

Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.

J Rheumatol 2014 Apr 15;41(4):688-97. Epub 2014 Jan 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and the Toronto Western Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.130005
Publisher Site
http://dx.doi.org/10.3899/jrheum.130005DOI Listing
April 2014
20 Reads
6 Citations
3.190 Impact Factor

The assessment of disease activity in rheumatic diseases.

Int J Rheumatol 2013 7;2013:275691. Epub 2013 Nov 7.

Weill Cornell Medical College in Qatar, Doha 24144, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/275691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838830PMC
December 2013
36 Reads

Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Curr Rheumatol Rep 2013 Dec;15(12):380

Allegheny Health Network, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11926-013-0380-9
Publisher Site
http://dx.doi.org/10.1007/s11926-013-0380-9DOI Listing
December 2013
11 Reads
2 Citations
2.454 Impact Factor

Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease.

J Rheumatol 2013 Oct 1;40(10):1726-35. Epub 2013 Sep 1.

From the Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto; Al Ain Hospital, Medical Institute, Al Ain, United Arab Emirates; and Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130048DOI Listing
October 2013
51 Reads
1 Citation
3.190 Impact Factor

GRAPPA Trainees Symposium 2012: a report from the GRAPPA 2012 annual meeting.

J Rheumatol 2013 Aug;40(8):1413-8

Division of Arthritis and Rheumatism, Oregon Health and Sciences University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130452DOI Listing
August 2013
3 Reads
3.190 Impact Factor

Systemic lupus erythematosus disease activity index 2000 responder index-50 website.

J Rheumatol 2013 May;40(5):733

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130030DOI Listing
May 2013
29 Reads
3.190 Impact Factor

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.

Expert Opin Biol Ther 2013 May 23;13(5):723-37. Epub 2013 Jan 23.

University of Toronto, Institute of Medical Science, Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.764411DOI Listing
May 2013
30 Reads
2 Citations
3.743 Impact Factor

Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis.

Semin Arthritis Rheum 2013 Apr 16;42(5):498-506. Epub 2013 Jan 16.

Hospital Library, The Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2012.08.002DOI Listing
April 2013
46 Reads
1 Citation
3.925 Impact Factor

Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.

Curr Opin Rheumatol 2013 Mar;25(2):164-70

University of Toronto, Toronto Western Research Institute, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/BOR.0b013e32835d2b7bDOI Listing
March 2013
15 Reads
1 Citation
4.890 Impact Factor

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.

Rheumatology (Oxford) 2012 Oct 19;51(10):1814-9. Epub 2012 Jun 19.

Department of Medicine, Division of Rheumatology, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/kes146DOI Listing
October 2012
33 Reads
5 Citations
4.475 Impact Factor

Does the change in season affect disease activity in patients with psoriatic arthritis?

Ann Rheum Dis 2012 Aug 13;71(8):1370-3. Epub 2012 Apr 13.

Psoriatic Arthritis Clinic, Centre for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto Western Research Institute, Toronto, Canada.

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2011-20120
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2011-201208DOI Listing
August 2012
15 Reads
1 Citation
10.380 Impact Factor

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

Rheumatology (Oxford) 2012 Mar 24;51(3):528-34. Epub 2011 Nov 24.

Toronto Western Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ker339DOI Listing
March 2012
2 Reads
5 Citations
4.475 Impact Factor

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.

J Rheumatol 2011 Nov 1;38(11):2395-9. Epub 2011 Sep 1.

University of Toronto Lupus Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110550DOI Listing
November 2011
46 Reads
3 Citations
3.190 Impact Factor

Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes.

Arthritis Care Res (Hoboken) 2011 Oct;63(10):1440-7

Centre for Prognosis Studiesin the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2011
8 Reads
5 Citations
4.713 Impact Factor

Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?

J Rheumatol 2011 Sep 1;38(9):1898-905. Epub 2011 Jul 1.

Centre for Prognosis Studies in the Rheumatic Diseases, Room 1E-409, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110007DOI Listing
September 2011
9 Reads
9 Citations
3.190 Impact Factor

Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire.

BMC Med Res Methodol 2011 Apr 20;11:52. Epub 2011 Apr 20.

Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2288-11-52DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111402PMC
April 2011
4 Reads
6 Citations
2.270 Impact Factor

Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.

J Rheumatol 2011 Feb 1;38(2):275-84. Epub 2010 Dec 1.

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Room 1E-409, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100724DOI Listing
February 2011
38 Reads
5 Citations
3.190 Impact Factor

Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time.

J Rheumatol 2011 Jan 15;38(1):60-3. Epub 2010 Nov 15.

University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Diseases, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100575DOI Listing
January 2011
41 Reads
3 Citations
3.190 Impact Factor

Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis.

J Rheumatol 2011 Jan 15;38(1):69-78. Epub 2010 Oct 15.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100130DOI Listing
January 2011
5 Reads
11 Citations
3.190 Impact Factor

TNF polymorphisms in patients with Behçet disease: a meta-analysis.

Arch Med Res 2010 Feb 24;41(2):142-6. Epub 2010 Mar 24.

Department of Internal Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2010.02.002DOI Listing
February 2010
7 Reads
15 Citations
2.410 Impact Factor

Successful treatment of cardiac involvement in dermatomyositis with rituximab.

Joint Bone Spine 2008 May 31;75(3):334-7. Epub 2007 Aug 31.

American University of Beirut Medical Center, Department of Internal Medicine, Division of Rheumatology, PO Box 11-0236 Riad El-Solh, Beirut 1107 2020, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2007.05.011DOI Listing
May 2008
9 Reads
2 Citations
2.901 Impact Factor

Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome.

J Clin Rheumatol 2007 Dec;13(6):338-40

Division of Rheumatology, Department of Internal Medicine, American University of Beirut Medical Center, Riad Solh Cairo Street, Beirut, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0b013e31815c65f5DOI Listing
December 2007
6 Reads
1.250 Impact Factor

Family history of lymphoma and risk for solid tumors in patients with Sjogren's syndrome.

Rheumatol Int 2007 Nov 12;28(1):87-8. Epub 2007 Jun 12.

Department of Internal Medicine, Division of Rheumatology, American University of Beirut Medical Center, 3 Dag Hammarskjold Plaza 8th floor, New York, NY 10017-2303, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-007-0370-1DOI Listing
November 2007
10 Reads
1 Citation
1.630 Impact Factor

Cardiac sarcoidosis responding to monotherapy with infliximab.

Clin Rheumatol 2007 Nov 30;26(11):2001-3. Epub 2007 Mar 30.

Department of Internal Medicine, Faculty of Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Hamra Street, Beirut, 1103 2090, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-007-0614-1DOI Listing
November 2007
3 Reads
7 Citations
1.774 Impact Factor

The use of TNF-alpha blockers in Cogan's syndrome.

Rheumatol Int 2007 Aug 13;27(10):995-6. Epub 2007 Jun 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-007-0373-yDOI Listing
August 2007
8 Reads
3 Citations
1.630 Impact Factor

Endobronchial stenting for respiratory complications in relapsing polychondritis.

Clin Rheumatol 2007 Feb 1;26(2):271-3. Epub 2006 Mar 1.

Department of Internal Medicine, American University of Beirut Medical Center, Cairo St., Hamra, P.O. Box 11-0236, Beirut, Lebanon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-005-0137-6DOI Listing
February 2007
8 Reads
1 Citation
1.774 Impact Factor

Successful retreatment with infliximab in patients with prior severe infusion reactions.

Clin Rheumatol 2006 Jul 7;25(4):540-1. Epub 2005 Oct 7.

Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10067-005-0029-9
Publisher Site
http://dx.doi.org/10.1007/s10067-005-0029-9DOI Listing
July 2006
4 Reads
1.774 Impact Factor

Response of deep cutaneous vasculitis to infliximab.

J Am Acad Dermatol 2005 Aug;53(2):353-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2005.02.009DOI Listing
August 2005
6 Reads
2 Citations
4.450 Impact Factor

Top co-authors

Dafna D Gladman
Dafna D Gladman

University of Toronto

26
Murray B Urowitz
Murray B Urowitz

Toronto Western Hospital

22
Jiandong Su
Jiandong Su

University of Toronto

11
Thurayya Arayssi
Thurayya Arayssi

American University of Beirut Medical Center

8
Lihi Eder
Lihi Eder

Toronto Western Hospital

7
Vinod Chandran
Vinod Chandran

Toronto Western Hospital

5
Nicole Anderson
Nicole Anderson

Rotman Research Institute

5
Sindhu R Johnson
Sindhu R Johnson

University of Toronto

4